SportsNation Blog Archives Clayton Kershaw
Dodgers without Clayton Kershaw?
The word on two-time National League Cy Young Award winner Clayton Kershaw isn't good. Although the Los Angeles Dodgers don't know when their ace will return, they say back inflammation will sideline the lefty for at least two to three weeks. Naturally this isn't great for the club; Kershaw posted an absurd 1.83 ERA a year ago. But the Dodgers aren't a one-man team, and were heavy favorites to win the NL West before the season started.
Clayton Kershaw, Dodgers agree
It wasn't unexpected, but still must give Los Angeles Dodgers fans quite a bit of relief: According to ESPN.com sources, the team and Clayton Kershaw agreed on a seven-year, $215 million deal. On one hand, it's a major risk, as pitchers are known to be vulnerable to unanticipated injuries. On the other, Kershaw turns 26 in March, and has won two of the last three NL Cy Young Awards (the lefty posted a 1.83 ERA in 2013). Also, the Dodgers aren't exactly in rebuilding mode; they won 92 games last season and reached the NLCS.
For the second straight year, traditional numbers beat out advanced metrics on the American League Most Valuable Player ballot, with the Detroit Tigers' Miguel Cabrera receiving the award over Mike Trout of the Los Angeles Angels. The scrape played out differently in the National League, where the Pittsburgh Pirates' Andrew McCutchen -- he of better modern numbers (but also more team wins) -- beat Paul Goldschmidt of the Arizona Diamondbacks. Do you agree with the picks?
Miguel Cabrera posted dazzling traditional numbers (.348 avg., 44 HRs, 137 RBIs) on a winner, while Mike Trout offered a better WAR.
Andrew McCutchen won the WAR with Paul Goldschmidt, but didn't slug as well (the latter had a 36-21 edge in homers and 125-84 in RBIs).
Who's No. 1?
Could a 22-year-old really be the premier player in the sport? Or is one of the MVPs better?